On 11 March 2020, the World Health Organization declared COVID-19 a
global pandemic. Since this declaration, compulsory licensing has remained a
hot topic in the IP world. The global and national response needed for shifting
the challenge to the promotion and protection of health and the human rights of
people across the globe. The situation which is existing today is like a global
public health emergency. So the countries identify the ways for addressing this
situation from the human rights perspective and to address the public health
concern successfully. Enjoyment of the highest attainable standard of health
which is the heart of the World Health Organization. WHO commitment continues
to serve health as a human right which continues to give a signal for the
countries to respond to the public health emergency.
Access to health can be directly related to the availability
of medical care as part of the person’s individuals rights, various
international convention Universal Declaration of Human Rights 1948,
International Covenant of Civil and Political Rights, International Covenant on
Economic, Social and Cultural Rights, Convention on the Elimination of all
Forms of Discrimination Against Women 1979, Convention on the Rights of Child. During this period, one of
the major responsibility for reducing the disruption of the health-care system
is on the pharmaceutical company by maintaining the supply of constant
medicines, diagnostic tools and vaccines for smooth functioning. Global supply
of pharmaceuticals is liked to be interrupted, particularly in the low and
middle-class family.
During this pandemic, a major focus of the pharmaceuticals company should not be on the profit
generation but to deal with this problem effectively by making medicine accessible
to the larger population. Health should be given priority over the revenue generation. This will also help the company to outshine his
image and name by providing the medicine at a low cost. While many countries
like Israel, Canada,
and Chile have
already taken measures to speed up licensing processes and have tweaked their
patent regime to dilute the rights of patent holders. There is enough pressure
from the public and media on private entities, including the pharma companies
which also push them toward sharing their products and patents more openly and
to make joint efforts for tackling the virus along with the emergency measures
taken up by the government to overcome the patent barrier. As the patent system
always encourages innovation especially in the pharmaceutical sector because it
recouped and profit margins attained.
Comments
Post a Comment
If you have any doubt just let me know